Table 1 Patients’ basic characteristics
From: An individualized immune prognostic signature in lung adenocarcinoma
No. of patients (n = 1337) | |
|---|---|
Affymetrix® platform | |
GPL570 | 520 (38.89%) |
GPL96 | 436 (32.61%) |
GPL10379 | 381 (28.50%) |
Age (years),mean(sd) | 65.20 (10.01) |
Sex ratio (M: F) | 657:680 |
Stage | |
I | 753 (56.32%) |
II | 428 (32.01%) |
III | 138 (10.32%) |
IV | 18 (1.35%) |
Purity, mean (SD) | 0.50 (0.15) |